Request Free Sample ×
Europe Vitamins Minerals Supplement Market Research Report - Forecast Till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Vitamins Minerals Supplement Market

ID: MRFR/FnB/45493-HCR
128 Pages
Garvit Vyas
Last Updated: April 24, 2026

Europe Vitamins and Minerals Supplement Market Size, Share, Industry Trend & Analysis Research Report: By Type (Vitamins, Minerals), By Form (Powder, CapsulesTablets, Liquid, Others), By End User (Men, Women, Unisex), By Application (Energy/Sports Nutrition, Weight Management, Immunity and Digestive Health, Anti-Cancer, Skin Care, GlycemicDiabetes Management, Other) andBy Distribution Channel (SupermarketsHypermarkets, Chemist/Pharmacies, Drugstores/Parapharamices, Online, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Europe Vitamins Minerals Supplement Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Vitamins
  50.     4.1.2 Minerals
  51.   4.2 Healthcare, BY Form (USD Billion)
  52.     4.2.1 Powder
  53.     4.2.2 Capsules & Tablets
  54.     4.2.3 Liquid
  55.     4.2.4 Others
  56.   4.3 Healthcare, BY End User (USD Billion)
  57.     4.3.1 Men
  58.     4.3.2 Women
  59.     4.3.3 Children
  60.   4.4 Healthcare, BY Application (USD Billion)
  61.     4.4.1 Energy/Sports Nutrition
  62.     4.4.2 Weight Management
  63.     4.4.3 Immunity and Digestive Health
  64.     4.4.4 Anti-Cancer
  65.     4.4.5 Skin Care
  66.     4.4.6 Glycemic & Diabetes Management
  67.     4.4.7 Other
  68.   4.5 Healthcare, BY Distribution Channel (USD Billion)
  69.     4.5.1 Supermarkets & Hypermarkets
  70.     4.5.2 Chemist/Pharmacies
  71.     4.5.3 Drugstores/Paraharmacies
  72.     4.5.4 Online
  73.     4.5.5 Others
  74. 5 SECTION V: COMPETITIVE ANALYSIS
  75.   5.1 Competitive Landscape
  76.     5.1.1 Overview
  77.     5.1.2 Competitive Analysis
  78.     5.1.3 Market share Analysis
  79.     5.1.4 Major Growth Strategy in the Healthcare
  80.     5.1.5 Competitive Benchmarking
  81.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  82.     5.1.7 Key developments and growth strategies
  83.       5.1.7.1 New Product Launch/Service Deployment
  84.       5.1.7.2 Merger & Acquisitions
  85.       5.1.7.3 Joint Ventures
  86.     5.1.8 Major Players Financial Matrix
  87.       5.1.8.1 Sales and Operating Income
  88.       5.1.8.2 Major Players R&D Expenditure. 2023
  89.   5.2 Company Profiles
  90.     5.2.1 Herbalife (US)
  91.       5.2.1.1 Financial Overview
  92.       5.2.1.2 Products Offered
  93.       5.2.1.3 Key Developments
  94.       5.2.1.4 SWOT Analysis
  95.       5.2.1.5 Key Strategies
  96.     5.2.2 Amway (US)
  97.       5.2.2.1 Financial Overview
  98.       5.2.2.2 Products Offered
  99.       5.2.2.3 Key Developments
  100.       5.2.2.4 SWOT Analysis
  101.       5.2.2.5 Key Strategies
  102.     5.2.3 GNC Holdings (US)
  103.       5.2.3.1 Financial Overview
  104.       5.2.3.2 Products Offered
  105.       5.2.3.3 Key Developments
  106.       5.2.3.4 SWOT Analysis
  107.       5.2.3.5 Key Strategies
  108.     5.2.4 Nature's Bounty (US)
  109.       5.2.4.1 Financial Overview
  110.       5.2.4.2 Products Offered
  111.       5.2.4.3 Key Developments
  112.       5.2.4.4 SWOT Analysis
  113.       5.2.4.5 Key Strategies
  114.     5.2.5 NOW Foods (US)
  115.       5.2.5.1 Financial Overview
  116.       5.2.5.2 Products Offered
  117.       5.2.5.3 Key Developments
  118.       5.2.5.4 SWOT Analysis
  119.       5.2.5.5 Key Strategies
  120.     5.2.6 Garden of Life (US)
  121.       5.2.6.1 Financial Overview
  122.       5.2.6.2 Products Offered
  123.       5.2.6.3 Key Developments
  124.       5.2.6.4 SWOT Analysis
  125.       5.2.6.5 Key Strategies
  126.     5.2.7 Swanson Health Products (US)
  127.       5.2.7.1 Financial Overview
  128.       5.2.7.2 Products Offered
  129.       5.2.7.3 Key Developments
  130.       5.2.7.4 SWOT Analysis
  131.       5.2.7.5 Key Strategies
  132.     5.2.8 Solgar (US)
  133.       5.2.8.1 Financial Overview
  134.       5.2.8.2 Products Offered
  135.       5.2.8.3 Key Developments
  136.       5.2.8.4 SWOT Analysis
  137.       5.2.8.5 Key Strategies
  138.   5.3 Appendix
  139.     5.3.1 References
  140.     5.3.2 Related Reports
  141. 6 LIST OF FIGURES
  142.   6.1 MARKET SYNOPSIS
  143.   6.2 EUROPE MARKET ANALYSIS BY TYPE
  144.   6.3 EUROPE MARKET ANALYSIS BY FORM
  145.   6.4 EUROPE MARKET ANALYSIS BY END USER
  146.   6.5 EUROPE MARKET ANALYSIS BY APPLICATION
  147.   6.6 EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  148.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  149.   6.8 RESEARCH PROCESS OF MRFR
  150.   6.9 DRO ANALYSIS OF HEALTHCARE
  151.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  152.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  153.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  154.   6.13 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  155.   6.14 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  156.   6.15 HEALTHCARE, BY FORM, 2024 (% SHARE)
  157.   6.16 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Billion)
  158.   6.17 HEALTHCARE, BY END USER, 2024 (% SHARE)
  159.   6.18 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  160.   6.19 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  161.   6.20 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  162.   6.21 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  163.   6.22 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  164.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  165. 7 LIST OF TABLES
  166.   7.1 LIST OF ASSUMPTIONS
  167.     7.1.1
  168.   7.2 Europe MARKET SIZE ESTIMATES; FORECAST
  169.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  170.     7.2.2 BY FORM, 2025-2035 (USD Billion)
  171.     7.2.3 BY END USER, 2025-2035 (USD Billion)
  172.     7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
  173.     7.2.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  174.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  175.     7.3.1
  176.   7.4 ACQUISITION/PARTNERSHIP
  177.     7.4.1

Europe Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Vitamins
  • Minerals

Healthcare By Form (USD Billion, 2025-2035)

  • Powder
  • Capsules & Tablets
  • Liquid
  • Others

Healthcare By End User (USD Billion, 2025-2035)

  • Men
  • Women
  • Children

Healthcare By Application (USD Billion, 2025-2035)

  • Energy/Sports Nutrition
  • Weight Management
  • Immunity and Digestive Health
  • Anti-Cancer
  • Skin Care
  • Glycemic & Diabetes Management
  • Other

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Supermarkets & Hypermarkets
  • Chemist/Pharmacies
  • Drugstores/Paraharmacies
  • Online
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓